Katacalcin: a new plasma calcium-lowering hormone

Area of Science:

• Endocrinology
• Molecular Biology
• Calcium Metabolism

Background:

• Calcitonin is a key hormone in calcium regulation.
• A second peptide, katacalcin (PDN-21), is found alongside calcitonin in the human precursor.
• The physiological role and concentrations of katacalcin were previously less understood.

Purpose of the Study:

• To investigate the presence and levels of plasma katacalcin in healthy individuals.
• To explore the relationship between plasma katacalcin, sex, and calcium levels.
• To assess the diagnostic utility of plasma katacalcin in medullary thyroid carcinoma.

Main Methods:

• Blood samples were collected from 57 healthy volunteers.
• Plasma katacalcin concentrations were measured.
• Calcium infusion was administered to assess dynamic changes.
• Plasma katacalcin levels were analyzed in 20 patients with medullary thyroid carcinoma.

Main Results:

• Plasma katacalcin was detected in all healthy volunteers.
• Concentrations were higher in males than females and equimolar to calcitonin.
• Plasma katacalcin levels doubled within 5 minutes of calcium infusion.
• Markedly elevated plasma katacalcin was observed in patients with medullary thyroid carcinoma.

Conclusions:

• Plasma katacalcin is a significant peptide involved in calcium homeostasis.
• Katacalcin levels correlate with sex and calcium challenges.
• Plasma katacalcin measurement shows promise for diagnosing and monitoring medullary thyroid carcinoma.
• Katacalcin may be a therapeutic target for bone diseases.